We are live on ! Find out more
DP

Dearborn Partners Portfolio holdings

AUM $1.77B
1-Year Est. Return 9.47%
This Fund
S&P 500
This Quarter Est. Return
-1.19%
1 Year Est. Return
+9.47%
3 Year Est. Return
+46.14%
5 Year Est. Return
+70.1%
10 Year Est. Return
+248.35%
AUM
$2.39B
AUM Growth
-$77M
Cap. Flow
-$31.6M
Cap. Flow %
-1.33%
Top 10 Hldgs %
27.24%
Holding
278
New
12
Increased
90
Reduced
122
Closed
19

Top Buys

Rank Stock Value
1
CTVA icon
Corteva
CTVA
+$31.8M
2
APH icon
Amphenol
APH
+$31.2M
3
SPYM
State Street SPDR Portfolio S&P 500 ETF
SPYM
+$718K
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$690K
5
IBDU icon
iShares iBonds Dec 2029 Term Corporate ETF
IBDU
+$522K

Top Sells

Rank Stock Value
1
ELV icon
Elevance Health
ELV
+$29.9M
2
GILD icon
Gilead Sciences
GILD
+$20.6M
3
CASY icon
Casey's General Stores
CASY
+$8.66M
4
CTAS icon
Cintas
CTAS
+$8.46M
5
RS icon
Reliance Steel & Aluminium
RS
+$4.76M

Sector Composition

Rank Sector Weight
1 Technology 25.72%
2 Industrials 14.79%
3 Financials 10.99%
4 Healthcare 10.98%
5 Consumer Discretionary 8.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EFA icon
251
iShares MSCI EAFE ETF
EFA
$77.6B
$215K 0.01%
2,842
– –
BMY icon
252
Bristol-Myers Squibb
BMY
$130B
$212K 0.01%
+3,755
New +$210K
BAX icon
253
Baxter International
BAX
$12.2B
$212K 0.01%
7,258
– –
IEX icon
254
IDEX
IEX
$16.3B
$209K 0.01%
1,001
– –
XLRE icon
255
State Street Real Estate Select Sector SPDR ETF
XLRE
$7.95B
$209K 0.01%
+5,131
New +$222K
DOV icon
256
Dover
DOV
$25.4B
$203K 0.01%
+1,081
New +$211K
CINF icon
257
Cincinnati Financial
CINF
$26.2B
$202K 0.01%
+1,403
New +$205K
IGC icon
258
IGC Pharma
IGC
$28.1M
$36.8K ﹤0.01%
109,401
-7,000
-6% -$2.62K
AMAT icon
259
Applied Materials
AMAT
$330B
– –
-1,404
Closed -$284K
AMD icon
260
Advanced Micro Devices
AMD
$837B
– –
-3,228
Closed -$530K
BABA icon
261
Alibaba
BABA
$267B
– –
-2,130
Closed -$226K
BCE icon
262
BCE
BCE
$21B
– –
-14,015
Closed -$488K
CVS icon
263
CVS Health
CVS
$117B
– –
-7,013
Closed -$441K
ELV icon
264
Elevance Health
ELV
$89.5B
– –
-57,547
Closed -$29.9M
FSLR icon
265
First Solar
FSLR
$20.5B
– –
-2,100
Closed -$524K
GGG icon
266
Graco
GGG
$12.4B
– –
-2,659
Closed -$233K
GPCR icon
267
Structure Therapeutics
GPCR
$2.53B
– –
-4,600
Closed -$202K
IBTF
268
DELISTED
iShares iBonds Dec 2025 Term Treasury ETF
IBTF
– –
-16,703
Closed -$391K
NEM icon
269
Newmont
NEM
$128B
– –
-5,500
Closed -$294K
NOC icon
270
Northrop Grumman
NOC
$75.4B
– –
-402
Closed -$212K
SJM icon
271
J.M. Smucker
SJM
$13.2B
– –
-1,817
Closed -$220K
SPG icon
272
Simon Property Group
SPG
$65.7B
– –
-1,652
Closed -$279K
TMO icon
273
Thermo Fisher Scientific
TMO
$240B
– –
-483
Closed -$299K
TROW icon
274
T. Rowe Price
TROW
$21.8B
– –
-1,851
Closed -$202K
XBI icon
275
State Street SPDR S&P Biotech ETF
XBI
$10.4B
– –
-2,705
Closed -$267K
8 9 10
11
12

Similar funds

FRA
Frank Rimerman Advisors Palo Alto, California $1.77B AUM 41.18% 1-Year Est. Return
PPC
Park Presidio Capital San Francisco, California $1.77B AUM 25.11% 1-Year Est. Return
CPCM
Cardinal Point Capital Management Toronto, Ontario, Canada $1.77B AUM 26.72% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return
SGAM
Stephens Group Asset Management Little Rock, Arkansas $1.77B AUM 17.59% 1-Year Est. Return
IP
Indivisible Partners Clearwater, Florida $1.77B AUM
CC
Covalis Capital London, United Kingdom $1.77B AUM 26.68% 1-Year Est. Return
FDP
Financiere des Professionnels Montreal, Quebec, Canada $1.77B AUM 34.52% 1-Year Est. Return

Dearborn Partners's Q4 2024 Portfolio in Review

As of Q4 2024, Dearborn Partners held 278 positions worth $2.39B, down 3.1% from $2.46B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Dearborn Partners's Q4 2024 filing shows 12 new, 90 increased, 122 reduced and 19 closed positions. Its largest new stake was iShares iBonds Dec 2029 Term Corporate ETF: 22,655 shares worth $517K. The largest sale was Elevance Health, an estimated $29.9M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Industrials and Financials.

  • Dearborn Partners's largest Q4 2024 buy was iShares iBonds Dec 2029 Term Corporate ETF: 22,655 shares worth $517K.
  • Dearborn Partners added most to Corteva in Q4 2024, an estimated $31.8M increase.
  • Dearborn Partners's biggest Q4 2024 reduction was Gilead Sciences, cutting an estimated $20.6M.
  • Dearborn Partners fully exited Elevance Health in Q4 2024, selling an estimated $29.9M.
  • Dearborn Partners's ten largest holdings make up 27% of its $2.39B portfolio in Q4 2024.
  • Dearborn Partners opened 12 new positions and closed 19 in Q4 2024.
  • Dearborn Partners's portfolio value fell 3.1% quarter-over-quarter to $2.39B.

Based on Dearborn Partners's 13F filing for Q4 2024, filed 7 Feb 2025.